M. Wójcik-Superczyńska

Efficacy of Osimertinib in Lung Squamous Cell Carcinoma Patients with EGFR Gene Mutation–Case Report and a Literature Review

P. Krawczyk, J. Milanowski, I. Chmielewska, 2022, Current oncology.

Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations.

P. Krawczyk, J. Milanowski, R. Ramlau, 2017, Oncology letters.

Analysis of ROS1 gene rearrangement incidence among NSCLC patients with fluorescent in situ hybridization technique

P. Krawczyk, J. Milanowski, R. Ramlau, 2020 .

In vitro preliminary study on different anti-PD-1 antibody concentrations on T cells activation

P. Krawczyk, J. Milanowski, I. Chmielewska, 2022, Scientific reports.

Exacerbation of symptoms of rheumatoid arthritis in the course of immunotherapy of non-small cell lung cancer - an analysis of medical cases and a review of the literature

J. Milanowski, I. Chmielewska, M. Wójcik-Superczyńska, 2022, Journal of Education, Health and Sport.

The Influence of Different Anti-PD-1 Monoclonal Antibody Concentrations On T Cell Activation in in - Vitro Culture – A Preliminary Study

P. Krawczyk, J. Milanowski, I. Chmielewska, 2021 .

Breaking the ‘Undruggable’ Barrier: Anti-PD-1/PD-L1 Immunotherapy for Non-Small Cell Lung Cancer Patients with KRAS Mutations—A Comprehensive Review and Description of Single Site Experience

P. Krawczyk, J. Milanowski, I. Chmielewska, 2023, Cancers.

Qualification for TKI-EGFR inhibitors treatment in a patient diagnosed with adenocarcinoma of the lung with activating mutation in EGFR gene

M. Wójcik-Superczyńska, S. Mańdziuk, 2014 .